Recombinant Monoclonal Anti-TPBG Antibody, Rabbit (P1B10)

This product is in development. If you are interested in this product, please contact us directly. We will accelerate our R&D process according to your needs and reserve the product for you.

Customer Reviews
Cat. No. / Size
Price
Qty
HGS-M2717-20ul
$ 135.00
HGS-M2717-100ul
$ 400.00

Product Details

  • Background

    Recombinant Monoclonal Anti-TPBG Antibody, Rabbit (P1B10) is a TPBG primary antibody for IHC application.
    TPBG is a leucine-rich transmembrane glycoprotein that is specific to trophoblast cells and is associated with cell adhesion. It is an oncofetal antigen that is highly expressed in many tumor cells in adults. TPBG protein localizes to the plasma membrane, cell surface, nucleoplasm, and axon terminus, and its expression is high in the endocrine system and respiratory system, with additional high expression in the proximal digestive tract. Clinically, TPBG is associated with poor outcome in numerous cancers, such as non-small cell lung cancer, breast cancer, colorectal cancer, cervical cancer, gastric cancer, kidney cancer so on.

  • Product Specifications

    Host Species
    Rabbit
    Isotype
    Rabbit IgG, Rabbit Kappa
    Clone
    P1B10
    Application
    IHC-P
    Form
    Liquid
    Clonality
    Monoclonal
    Reactivity
    Human
    Synonyms
    5T4, WAIF1
    Concentration
    0.9~1.1 mg/ml
    Specificity
    React with TPBG protein on the membrane of target cell/tissue
  • Storage

    Shipped at 4°C, Blue Ice. Store at +4°C for short term (1-2 weeks). Store at -20°C for long term.
    Avoid freeze / thaw cycle. Upon delivery aliquot. The shelf life is 30 days from the date of opening.

  • ACRO Quality Management System

    1. QMS(ISO, GMP)
    2. Quality Advantages
    3. Quality Control Process

Customers Also Viewed

Customer Reviews
Writing Reviews

Recent Advances

 
Drug Development Progress
  • English Name:

    Trophoblast glycoprotein

  • Category:

  • Approved Drugs:

    0 Details

  • Drugs in Clinical Trials:

    16 Details

  • Highest Development Stage:

    Phase 2 Clinical

Drug Candidate Licensing
More
  • Basic Product Information
  • Product Details
  • Customers Also Viewed
  • Customer Reviews